Product
Currency:CNY
2024/H1
Stock NameRevenueRatio
Preparation product663.03M37.70%
Other pharmaceutical and chemical products447.55M25.45%
Cefazal side chain active ester series438.96M24.96%
Series of Biopharmaceutical and characteristic API products209.05M11.89%
Industry
Currency:CNY
2024/H1
Stock NameRevenueRatio
Intermediate segment868.2M49.37%
Preparation division679.33M38.63%
Other211.05M12.00%
Region
Currency:CNY
2024/H1
Stock NameRevenueRatio
Domestic sales1.38B78.69%
Foreign sales374.8M21.31%